CB Insights has named Healthy.io one of the world’s most promising AI startups. This year’s prestigious AI 100 list—selected from a pool of nearly 5,000 companies—includes 100 startups spanning 13 countries across 15 industries, with over $7.4 billion dollars in funding.
Healthcare is the most represented industry this year, with 13 digital health startups rounding out the list. We are proud to share the honor with other companies doing groundbreaking work in the healthcare space, such as Viz.ai, which uses AI to detect strokes, or the fellow Israeli company Zebra Medical Vision, which develops image recognition tools for radiologists.
The CB Insights research team used an evidence-based approach to select the AI 100 based on factors such as patent activity, business relations, investor profile, news sentiment analysis, competitive landscape, team strength, and tech novelty.
Healthy.io is the global pioneer in turning the smartphone camera into a clinical-grade medical device. Our smartphone-powered urinalysis product has been used by tens of thousands of patients around the world.
The product uses AI and machine learning algorithms to recognize the urine dipstick’s true colors, regardless of the wide variance in smartphone camera type and lighting conditions, to provide consistent test results that are equivalent to lab testing.
Our digital wound management solution leverages the same computer vision and color calibration technology to allow wound care clinicians to accurately measure and assess chronic wounds, and monitor their progress over time.
“We’re proud to be recognized alongside such an impressive group of companies. It’s no surprise that healthcare is the top industry in this year’s list. We’ve seen a real shift from the early generic AI promise of the computer replacing the doctor, to solutions that empower clinicians to solve specific problems, and make a valuable impact in the communities they serve. Using AI, we’ve enabled the smartphone camera to test for urinary tract infections, to detect chronic kidney disease in its early stages, and to scan and track the healing of chronic wounds. Over the years, AI has helped us offer clinical-grade services to many people, and gain their trust. The potential is limitless, and we’re just getting started.”
Fast Facts about the AI 100 of 2020
- Raised over $7.4B in funding across 300+ deals from 600+ unique investors
- 10 unicorn companies with a valuation of $1 billion or more
- 13 different countries represented: 65% of the companies are American, and three are Israeli (Healthy.io, Zebra Medical Vision, and Razor Labs)
- 15 core fields, including energy, education, retail & warehousing, and transportation
- 48 companies from the 2019 AI 100 went on to raise $4.9B of additional funding
